Review article · 2026

Artificial intelligence in drug discovery — what it is, where we stand and the path forward

Andreas Bender, Morgan C. Thomas, Jack W. Scannell, David A. Shaywitz, Gian Marco Ghiandoni, Joe G. Greener, Lavinia-Lorena Pruteanu, Rachel DeVay Jacobson, Koichi Handa, Mariko Hirano, Srijit Seal, Manas Mahale and 4 more

Nature Reviews Drug Discovery, 25(11), 855–876 · Published 7 August 2026 · DOI 10.1038/s41573-026-01496-2

View at the publisherCite this paper

In brief

“Artificial intelligence in drug discovery — what it is, where we stand and the path forward” is a 2026 review article by Andreas Bender and 15 co-authors, published in Nature Reviews Drug Discovery. OpenAlex counts 32 citations as of 16 November 2026, which puts it in the top 1% of works published in 2026 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
32
Most cited in
2026 (32)
Field-weighted impact
10.70
References
209
Authors
16

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Bender, A., Thomas, M. C., Scannell, J. W., Shaywitz, D. A., Ghiandoni, G. M., Greener, J. G., Pruteanu, L.-L., Jacobson, R. D., Handa, K., Hirano, M., Seal, S., Mahale, M., Schmidt, M. F., Ahfeldt, T., Grisoni, F., & Cortés‐Ciriano, I. (2026). Artificial intelligence in drug discovery — what it is, where we stand and the path forward. Nature Reviews Drug Discovery, 25(11), 855–876. https://doi.org/10.1038/s41573-026-01496-2

MLA 9

Bender, Andreas, et al. “Artificial intelligence in drug discovery — what it is, where we stand and the path forward.” Nature Reviews Drug Discovery, vol. 25, no. 11, 2026, pp. 855–876. https://doi.org/10.1038/s41573-026-01496-2.

Chicago

Bender, Andreas, Morgan C. Thomas, Jack W. Scannell, David A. Shaywitz, Gian Marco Ghiandoni, Joe G. Greener, Lavinia-Lorena Pruteanu, et al. 2026. “Artificial intelligence in drug discovery — what it is, where we stand and the path forward.” Nature Reviews Drug Discovery 25 (11): 855–876. https://doi.org/10.1038/s41573-026-01496-2.

Harvard

Bender, A. et al. (2026) ‘Artificial intelligence in drug discovery — what it is, where we stand and the path forward’, Nature Reviews Drug Discovery, 25(11), pp. 855–876. doi:10.1038/s41573-026-01496-2.

IEEE

A. Bender et al., “Artificial intelligence in drug discovery — what it is, where we stand and the path forward,” Nature Reviews Drug Discovery, vol. 25, no. 11, pp. 855–876, 2026, doi: 10.1038/s41573-026-01496-2.

BibTeX

@article{bender2026artificial,
  title     = {{Artificial intelligence in drug discovery — what it is, where we stand and the path forward}},
  author    = {Bender, Andreas and Thomas, Morgan C. and Scannell, Jack W. and Shaywitz, David A. and Ghiandoni, Gian Marco and Greener, Joe G. and Pruteanu, Lavinia-Lorena and Jacobson, Rachel DeVay and Handa, Koichi and Hirano, Mariko and Seal, Srijit and Mahale, Manas and Schmidt, Marco F. and Ahfeldt, Tim and Grisoni, Francesca and Cortés‐Ciriano, Isidro},
  journal   = {Nature Reviews Drug Discovery},
  year      = {2026},
  volume    = {25},
  number    = {11},
  pages     = {855--876},
  doi       = {10.1038/s41573-026-01496-2},
  url       = {https://doi.org/10.1038/s41573-026-01496-2}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods

  • artificial intelligence
  • drug discovery
  • clinical translation
  • translational relevance
  • problem formulation
  • model validation
  • drug development decision-making

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Bender, A., Thomas, M. C., Scannell, J. W., Shaywitz, D. A., Ghiandoni, G. M., Greener, J. G., Pruteanu, L.-L., Jacobson, R. D., Handa, K., Hirano, M., Seal, S., Mahale, M., Schmidt, M. F., Ahfeldt, T., Grisoni, F., & Cortés‐Ciriano, I. (2026). Artificial intelligence in drug discovery — what it is, where we stand and the path forward. Nature Reviews Drug Discovery, 25(11), 855–876. https://doi.org/10.1038/s41573-026-01496-2

How many times has this paper been cited?

32 times, according to OpenAlex on 16 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Andreas Bender, Morgan C. Thomas, Jack W. Scannell, David A. Shaywitz, Gian Marco Ghiandoni, Joe G. Greener, Lavinia-Lorena Pruteanu, Rachel DeVay Jacobson, Koichi Handa, Mariko Hirano, Srijit Seal, Manas Mahale and 4 more.

What is the DOI of this paper?

10.1038/s41573-026-01496-2, permanently at https://doi.org/10.1038/s41573-026-01496-2. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 16 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.